Is there an overlooked “window of opportunity” in MS exercise therapy? Perspectives for early MS rehabilitation

Morten Riemenschneider*, Lars G. Hvid, Egon Stenager, Ulrik Dalgas

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Resumé

While early medical treatment has proven effective in MS, early-phase MS rehabilitation has not gained much attention in MS research and clinical practice. Exercise therapy is one of the most promising treatment strategies in MS rehabilitation. Here, we provide a topical review investigating when exercise therapy is initiated in existing MS studies, showing that exercise is initiated at a rather late disease stage, where it predominantly serves as a symptomatic treatment. Recent findings in MS suggest that exercise may have neuroprotective and disease-modifying effects. Such findings along with the findings from medical trials that an early-stage “window of opportunity” exists leads to the proposal that early exercise therapy should be an increased focus in research and clinical practice for persons with MS. A further perspective relates to other rehabilitation interventions that are also initiated at a later disease stage, as these may also take advantage of an early-phase approach.

OriginalsprogEngelsk
TidsskriftMultiple sclerosis
Vol/bind24
Udgave nummer7
Sider (fra-til)886-894
ISSN1352-4585
DOI
StatusUdgivet - jun. 2018

Fingeraftryk

Research

Citer dette

Riemenschneider, Morten ; Hvid, Lars G. ; Stenager, Egon ; Dalgas, Ulrik. / Is there an overlooked “window of opportunity” in MS exercise therapy? Perspectives for early MS rehabilitation. I: Multiple sclerosis. 2018 ; Bind 24, Nr. 7. s. 886-894.
@article{4c2e2f1bad5246aaa3becd261a00278f,
title = "Is there an overlooked “window of opportunity” in MS exercise therapy? Perspectives for early MS rehabilitation",
abstract = "While early medical treatment has proven effective in MS, early-phase MS rehabilitation has not gained much attention in MS research and clinical practice. Exercise therapy is one of the most promising treatment strategies in MS rehabilitation. Here, we provide a topical review investigating when exercise therapy is initiated in existing MS studies, showing that exercise is initiated at a rather late disease stage, where it predominantly serves as a symptomatic treatment. Recent findings in MS suggest that exercise may have neuroprotective and disease-modifying effects. Such findings along with the findings from medical trials that an early-stage “window of opportunity” exists leads to the proposal that early exercise therapy should be an increased focus in research and clinical practice for persons with MS. A further perspective relates to other rehabilitation interventions that are also initiated at a later disease stage, as these may also take advantage of an early-phase approach.",
keywords = "early treatment, exercise therapy, Multiple sclerosis, rehabilitation, window of opportunity",
author = "Morten Riemenschneider and Hvid, {Lars G.} and Egon Stenager and Ulrik Dalgas",
year = "2018",
month = "6",
doi = "10.1177/1352458518777377",
language = "English",
volume = "24",
pages = "886--894",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications",
number = "7",

}

Is there an overlooked “window of opportunity” in MS exercise therapy? Perspectives for early MS rehabilitation. / Riemenschneider, Morten; Hvid, Lars G.; Stenager, Egon; Dalgas, Ulrik.

I: Multiple sclerosis, Bind 24, Nr. 7, 06.2018, s. 886-894.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - Is there an overlooked “window of opportunity” in MS exercise therapy? Perspectives for early MS rehabilitation

AU - Riemenschneider, Morten

AU - Hvid, Lars G.

AU - Stenager, Egon

AU - Dalgas, Ulrik

PY - 2018/6

Y1 - 2018/6

N2 - While early medical treatment has proven effective in MS, early-phase MS rehabilitation has not gained much attention in MS research and clinical practice. Exercise therapy is one of the most promising treatment strategies in MS rehabilitation. Here, we provide a topical review investigating when exercise therapy is initiated in existing MS studies, showing that exercise is initiated at a rather late disease stage, where it predominantly serves as a symptomatic treatment. Recent findings in MS suggest that exercise may have neuroprotective and disease-modifying effects. Such findings along with the findings from medical trials that an early-stage “window of opportunity” exists leads to the proposal that early exercise therapy should be an increased focus in research and clinical practice for persons with MS. A further perspective relates to other rehabilitation interventions that are also initiated at a later disease stage, as these may also take advantage of an early-phase approach.

AB - While early medical treatment has proven effective in MS, early-phase MS rehabilitation has not gained much attention in MS research and clinical practice. Exercise therapy is one of the most promising treatment strategies in MS rehabilitation. Here, we provide a topical review investigating when exercise therapy is initiated in existing MS studies, showing that exercise is initiated at a rather late disease stage, where it predominantly serves as a symptomatic treatment. Recent findings in MS suggest that exercise may have neuroprotective and disease-modifying effects. Such findings along with the findings from medical trials that an early-stage “window of opportunity” exists leads to the proposal that early exercise therapy should be an increased focus in research and clinical practice for persons with MS. A further perspective relates to other rehabilitation interventions that are also initiated at a later disease stage, as these may also take advantage of an early-phase approach.

KW - early treatment

KW - exercise therapy

KW - Multiple sclerosis

KW - rehabilitation

KW - window of opportunity

UR - http://www.scopus.com/inward/record.url?scp=85048480269&partnerID=8YFLogxK

U2 - 10.1177/1352458518777377

DO - 10.1177/1352458518777377

M3 - Review

VL - 24

SP - 886

EP - 894

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

SN - 1352-4585

IS - 7

ER -